Wall Street’s Top Analysts Upgrades, Downgrades & Initiations

Wall Street’s Top Analysts Upgrades, Downgrades & Initiations


Daily HeffX-LTN reviews Wall Street analysts research reports to find new investing and trading ideas for our readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of Wall Street’s Top analysts upgrades, downgrades and initiations for Wednesday, as follows:

Biogen Inc. (NASDAQ:BIIB) analysts raised to Buy from Neutral with a 400 price target at Mizuho. Stifel raised its rating to Buy from Hold with a 415 price target. The consensus analyst target was 336.79 ahead of the calls, and Biogen has a 52-wk trading range of 244.28 – 344.37.

 Emerson Electric Co. (NYSE:EMR) was raised to Buy from Neutral with a 79 price objective at Merrill Lynch. The consensus target price was 62.28 prior to this call, and the 52-wk trading range is 49.38 – 64.92.

Netflix Inc. (NASDAQ:NFLX) Jefferies reiterated its Hold rating and raised its target to 190 from 180, and Wedbush maintained its Underperform rating while raising its target to 93 from 88 based on cash flow burn. FBR Capital Markets reiterated its Buy rating but raised its target to 207 from172. Loop Capital reiterated its Buy rating and raised its target to 242 from 228.

UnitedHealth Group Inc. (NYSE:UNH) analysts started with an Outperform rating and assigned a 250 price target at BMO Capital Markets. It has a consensus target price of 211.78 and a 52-wk trading range of 136.22 to 200.76. This is now the highest price target on Wall Street, as Thomson Reuters showed the prior street-high target at 235.

Stay tuned…

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

Latest posts by Paul Ebeling (see all)

You must be logged in to post comments :